These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 25463548)

  • 21. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression.
    Kaukinen P; Sillanpää M; Kotenko S; Lin R; Hiscott J; Melén K; Julkunen I
    Virol J; 2006 Sep; 3():66. PubMed ID: 16945160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus.
    Bender S; Reuter A; Eberle F; Einhorn E; Binder M; Bartenschlager R
    PLoS Pathog; 2015 Nov; 11(11):e1005264. PubMed ID: 26588843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease.
    Hiscott J; Lacoste J; Lin R
    Biochem Pharmacol; 2006 Nov; 72(11):1477-84. PubMed ID: 16876765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
    Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
    J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor.
    Yang Y; Liang Y; Qu L; Chen Z; Yi M; Li K; Lemon SM
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7253-8. PubMed ID: 17438296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses.
    Qu L; Lemon SM
    Semin Liver Dis; 2010 Nov; 30(4):319-32. PubMed ID: 20960373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enterovirus 2Apro targets MDA5 and MAVS in infected cells.
    Feng Q; Langereis MA; Lork M; Nguyen M; Hato SV; Lanke K; Emdad L; Bhoopathi P; Fisher PB; Lloyd RE; van Kuppeveld FJ
    J Virol; 2014 Mar; 88(6):3369-78. PubMed ID: 24390337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory of genetics and physiology 2 (LGP2) plays an essential role in hepatitis C virus infection-induced interferon responses.
    Hei L; Zhong J
    Hepatology; 2017 May; 65(5):1478-1491. PubMed ID: 28090671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
    Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
    J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.
    Brownell J; Wagoner J; Lovelace ES; Thirstrup D; Mohar I; Smith W; Giugliano S; Li K; Crispe IN; Rosen HR; Polyak SJ
    J Hepatol; 2013 Oct; 59(4):701-8. PubMed ID: 23770038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NOD1 Participates in the Innate Immune Response Triggered by Hepatitis C Virus Polymerase.
    Vegna S; Gregoire D; Moreau M; Lassus P; Durantel D; Assenat E; Hibner U; Simonin Y
    J Virol; 2016 Jul; 90(13):6022-6035. PubMed ID: 27099311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus reveals a novel early control in acute immune response.
    Arnaud N; Dabo S; Akazawa D; Fukasawa M; Shinkai-Ouchi F; Hugon J; Wakita T; Meurs EF
    PLoS Pathog; 2011 Oct; 7(10):e1002289. PubMed ID: 22022264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
    Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic Interaction of Stress Granules, DDX3X, and IKK-α Mediates Multiple Functions in Hepatitis C Virus Infection.
    Pène V; Li Q; Sodroski C; Hsu CS; Liang TJ
    J Virol; 2015 May; 89(10):5462-77. PubMed ID: 25740981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
    Paz S; Sun Q; Nakhaei P; Romieu-Mourez R; Goubau D; Julkunen I; Lin R; Hiscott J
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):17-28. PubMed ID: 16914100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS.
    Lifland AW; Jung J; Alonas E; Zurla C; Crowe JE; Santangelo PJ
    J Virol; 2012 Aug; 86(15):8245-58. PubMed ID: 22623778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses.
    Oshiumi H; Miyashita M; Matsumoto M; Seya T
    PLoS Pathog; 2013; 9(8):e1003533. PubMed ID: 23950712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.
    Saito T; Hirai R; Loo YM; Owen D; Johnson CL; Sinha SC; Akira S; Fujita T; Gale M
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):582-7. PubMed ID: 17190814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity.
    Loo YM; Fornek J; Crochet N; Bajwa G; Perwitasari O; Martinez-Sobrido L; Akira S; Gill MA; García-Sastre A; Katze MG; Gale M
    J Virol; 2008 Jan; 82(1):335-45. PubMed ID: 17942531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
    Israelow B; Narbus CM; Sourisseau M; Evans MJ
    Hepatology; 2014 Oct; 60(4):1170-9. PubMed ID: 24833036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.